LetterCorrespondence
Neuromuscular Blocking Agents for ARDS: Incentive for Personalized Medicine
Heather Torbic, Sudhir Krishnan and Abhijit Duggal
Respiratory Care May 2021, 66 (5) 888; DOI: https://doi.org/10.4187/respcare.08963
Heather Torbic
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio
Sudhir Krishnan
Department of Critical Care
Respiratory Institute
Cleveland Clinic
Cleveland, Ohio
Abhijit Duggal
Department of Critical Care
Respiratory Institute
Cleveland Clinic
Cleveland, Ohio

References
- 1.↵
- Torbic H,
- Krishnan S,
- Harnegie MP,
- Duggal A
- 2.↵
- Slutsky AS
- 3.
- Gattinoni L,
- Marini JJ
- 4.↵
- 5.↵
- 6.↵
- Andrade C
- 7.↵
- 8.↵Cochrane Scientific Committee. Should Cochrane apply error-adjustment methods when conducting repeated meta-analyses? 2018. Available at: https://methods.cochrane.org/sites/default/files/public/uploads/tsa_expert_panel_guidance_and_recommendation_final.pdf. Accessed February 1, 2021.
- 9.↵
- Murray MJ,
- DeBlock H,
- Erstad B,
- Gray A,
- Jacobi J,
- Jordan C,
- et al
- 10.↵
- 11.↵
- Calfee CS,
- Delucchi K,
- Parsons PE,
- Thompson BT,
- Ware LB,
- Matthay MA
- 12.↵
- Calfee CS,
- Delucchi KL,
- Sinha P,
- Matthay MA,
- Hackett J,
- Shankar-Hari M,
- et al
In this issue
Respiratory Care
Vol. 66, Issue 5
1 May 2021
Neuromuscular Blocking Agents for ARDS: Incentive for Personalized Medicine
Heather Torbic, Sudhir Krishnan, Abhijit Duggal
Respiratory Care May 2021, 66 (5) 888; DOI: 10.4187/respcare.08963